@article{b4b05cad1cdc4d30a161ae48e4532ff2,
title = "Heart valve disease among patients with hyperprolactinemia: a nationwide population-based cohort study",
abstract = "Increased risk of heart valve disease during treatment with certain dopamine agonists, such as cabergoline, has been observed in patients with Parkinson's disease. The same compound is used to treat hyperprolactinemia, but it is unknown whether this also associates with heart valve disease.",
keywords = "Adult, Aged, Aged, 80 and over, Denmark, Female, Follow-Up Studies, Heart Valve Diseases, Humans, Hyperprolactinemia, Incidence, Male, Middle Aged, Risk Factors",
author = "Steffensen, {Charlotte Kahlen} and Maegbaek, {Merete Lund} and Laurberg, {Peter Marsvin} and Marianne Andersen and Kistorp, {Caroline Micheala Nervil} and Helene Norrelund and {Toft Sorensen}, Henrik and Jorgensen, {Jens Otto Lunde}",
year = "2012",
doi = "10.1210/jc.2011-3257",
language = "English",
volume = "97",
pages = "1629--34",
journal = "Journal of Clinical Endocrinology and Metabolism",
issn = "0021-972X",
publisher = "Endocrine Society",
number = "5",
}